Shares of Johnson & Johnson have moved lower in late morning trading after the United States Court of Appeals for the Third Circuit court rejected the company’s plan to use a legal strategy to push about 38,000 talc lawsuits into bankruptcy court. In a ruling posted to the court’s site, the circuit judges wrote: "These cases came to be heard on the record before the United States Bankruptcy Court for the District of New Jersey and were argued on September 19, 2022. On consideration whereof, it is ordered and adjudged by this Court that the order of the Bankruptcy Court entered March 2, 2022 is reversed and the case is remanded with the instruction to dismiss Appellee’s Chapter 11 petition. The order of the Bankruptcy Court entered March 4, 2022 is vacated as moot." In Monday morning trading following news of the appeals court ruling, shares of Johnson & Johnson are down $4.46, or 3%, to $163.76.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on JNJ:
- Legal Trouble Hits JNJ Shares
- Are You Seeking Passive Income? Try These 2 Dividend Kings
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
